J2 Ventures — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Kusari provides visibility and remediation across software supply chains through vulnerability detection, dependency mapping, and automated fixes.
CybersecurityDeveloper ToolsSaaSRidgefield, US
Parth Patel(Executive Officer, Director)Tim Miller(Executive Officer, Director)Michael Lieberman(Executive Officer, Director)
Sealonix develops hemostatic sealants based on proprietary biomaterials to control surgical bleeding, targeting surgeons and patients undergoing abdominopelvic and other surgical procedures.
BiotechMedical DevicesNew MaterialsBedford, US
Amarpreet Sawhney(Executive Officer, Director)Amar Sawhney(Founder)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.